Pharmaceutical Industry Medicaid Pharmaceutical Policy Pharmaceuticals Regulation Caregiving Voting Rights Public Health Medical Education Health Insurance Insurance Regulations Child Gender Services Reproductive Rights Access to Healthcare Community Health Drug Approval Transportation Medicare Transgender Healthcare Nursing Homes Training Programs Vaccine Procurement Affordable Care Act Obamacare Electric Vehicles Biotechnology Manufacturing Gender-Affirming Care Long-term Care MedTech Terminal Illness Pharmaceutical Regulations Disability Services Reforms Insurance
The inquiry seeks to determine whether German reimbursement rules unfairly depress payments for innovative medicines, potentially paving the way for tariffs or other trade remedies.
